Physician profile
Anna Doucette
NPI 1225856727
$1,310.06
in general payments reported to CMS, 2019-2025
14 companies · $1,289 in 2025
The $1,289 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $21.07 · 2025: $1,289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,136 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,136.35 |
| Education | $173.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $422.99 | 2024-2025 | |
| Glaxosmithkline, LLC. | $203.22 | 2025 | Nucala |
| Jazz Pharmaceuticals INC. | $165.18 | 2025 | |
| Lilly USA, LLC | $161.41 | 2025 | Zepbound |
| Regeneron Healthcare Solutions, INC. | $73.72 | 2025 | Dupixent |
| Axsome Therapeutics, INC. | $68.18 | 2025 | Sunosi |
| Genentech USA, INC. | $42.15 | 2025 | Xolair |
| Optinose US, INC. | $40.58 | 2025 | |
| Aerin Medical INC. | $36.51 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $29.46 | 2024-2025 | |
| Integra Lifesciences Corporation | $23.20 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Ars Pharmaceuticals Operations, INC. | $15.30 | 2025 | Neffy |
| Astrazeneca Pharmaceuticals LP | $14.97 | 2025 | Tezspire |
| Phathom Pharmaceuticals, INC. | $13.19 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Doucette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.